Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIVOSIRAN vs GLIVEC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GIVOSIRAN vs GLIVEC: Safety Overview

Metric GIVOSIRAN GLIVEC
Total FAERS Reports 1,224 995
Deaths Reported 32 769
Death Rate 2.6% 77.3%
Hospitalizations 595 131
Average Patient Age 45.1 yrs 51.9 yrs
% Female Patients 89.5% N/A
FDA Approval Date Nov 20, 2019 N/A
Manufacturer Alnylam Pharmaceuticals, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A